Antihistamine — Omalizumab — Immunotherapy — Vaccine — Urticaria — Contact Dermatitis — Rinvoq
To clearly understand the clinical aspects involved in Contact Dermatitis This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Antihistamine — Omalizumab — Immunotherapy — Vaccine — Urticaria — Contact Dermatitis — Rinvoq" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Therapeutic Management of Urticaria, Use of Omalizumab, and Approaches to Systemic Contact Dermatitis
The management of chronic and complex allergic conditions, such as urticaria and systemic contact dermatitis, requires a thorough understanding of current clinical guidelines, as well as a rigorous investigation of the underlying causes. Frequent questions in the physician's office involve the combination of therapies, the effectiveness of monoclonal antibodies, and the role of immunotherapy and new immunomodulatory drugs.
Concomitant use of antihistamines and immunobiologicals
A recurring question among patients undergoing omalizumab treatment is whether they need to discontinue antihistamines. According to medical guidelines, antihistamine use should be maintained during treatment with the monoclonal antibody, as well as allergen-specific immunotherapy (allergy vaccines), if the patient is already using it to control associated respiratory comorbidities, such as moderate allergic asthma or rhinitis.
It is important to highlight that allergen-specific immunotherapy is not the first-line treatment for common urticaria. Its use is restricted and carefully considered in specific cases of chronic spontaneous allergic urticaria, with confirmed diagnosis of positivity for aeroallergens and concomitant respiratory diseases. The procedure consists of administering progressive and highly diluted doses to induce immunological tolerance, following a principle analogous to the induction of food tolerance in milk protein allergies.
Etiological investigation in refractory chronic urticaria
When a patient reports a lack of satisfactory clinical improvement with the use of omalizumab—a highly effective humanized monoclonal antibody against the IgE receptor—the first fundamental step is to conduct a broad and thorough clinical investigation. The specialist must act with an integrative approach to clinical medicine to identify potential hidden inflammatory or infectious foci that perpetuate the allergic condition, such as:
- Chronic infections, such as prostatitis in men or pelvic inflammatory disease in women.
- Dental foci (endodontic diseases and periodontitis).
- Gastrointestinal infections, such as gastritis associated with bacteria Helicobacter pylori and intestinal parasites in children.
- Rheumatic diseases and autoimmune endocrinopathies, such as Hashimoto's thyroiditis.
If exhaustive investigation reveals no other etiologies and the standard dose of omalizumab (150 mg to 300 mg monthly) does not achieve adequate control, the medical literature contemplates dose adjustment up to 600 mg every 15 days, under strict medical supervision. In cases of total refractoriness to this optimized dosage, the attending physician may evaluate the transition to alternative immunosuppressive therapies.
Systemic contact dermatitis and new therapeutic horizons
Systemic contact eczema can be triggered by internal exposure to metals present in implanted medical devices, such as orthopedic prostheses (for example, hip prostheses) and pacemakers. Managing reactions to implanted metals is challenging, as surgical removal of the device involves considerable risks and scientific debate regarding potential bone complications and severe inflammatory reactivations.
In complex and difficult-to-manage clinical situations, preliminary studies and scientific investigations have evaluated the potential use of advanced therapies. Among these, monoclonal antibodies that block interleukins (such as dupilumab, which inhibits IL-4 and IL-13 pathways) and Janus kinase inhibitors (JAK inhibitors, such as upadacitinib) stand out. These medications act by blocking intracellular signaling cascades and the production of inflammatory mediators responsible for severe eczematous manifestations. However, such therapeutic approaches are often still under study or off-label, requiring thorough discussion between the patient and the specialist physician.
Explanatory note: This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized medical evaluation performed by a specialist.
Developments in Evidence-Based Medicine: Pharmacology of Immunobiologics and Precision Medicine
In Evidence-Based Medicine, the indication of immunobiological agents (monoclonal antibodies and receptor fusion proteins) It is based on the patient's inflammatory endotyping. Selective blocking of molecular targets — such as the neutralization of free IgE by omalizumab (in severe allergic asthma and chronic spontaneous urticaria refractory to quadrupled-dose H1 antihistamines), the dual inhibition of IL-4 and IL-13 interleukin signaling by dupilumab (In moderate to severe atopic dermatitis, eosinophilic/Th2 asthma, and chronic rhinosinusitis with nasal polyposis), the blockade of the TSLP epithelial alarm by tezepelumab or blocking the IL-5/IL-5R pathway — allows control of the inflammatory cascade at its cellular origin, reducing exacerbations and sparing the patient from the adverse metabolic, endocrine, and cardiovascular effects of prolonged systemic corticosteroid use.
💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Skin Barrier Health, Immune Inflammation, and Pruritus Control
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Therapeutic Hydration, Skin Tests and Immunotherapy
The daily pillar of protection consists of immediate intensive hydration after quick, lukewarm showers with syndet cleansers (without alkaline soap), combined with personalized protocols of... treatment of atopic dermatitisIn causal investigation, the allergy test (whether it's a prick test for aeroallergens or a patch test for chemicals) guides precise avoidance measures and enables the indication of allergy vaccine in patients sensitized to dust mites.
Mast Cell Activation, Histamine, and the Bradykinin Pathway
When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.
Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E
Monoclonal antibodies (immunobiologics) have revolutionized the management of severe allergic and immune-mediated diseases that do not achieve full control with conventional therapies. Unlike systemic corticosteroids and classic immunosuppressants—which broadly depress immunity and generate metabolic toxicity—immunobiologics act as highly precise molecular keys, neutralizing specific targets of the inflammatory cascade: such as circulating free IgE (omalizumab), the IL-4 and IL-13 receptor (dupilumab), the eosinophilic pathway of IL-5 (mepolizumab and benralizumab), or the epithelial alarmin TSLP (tezepelumab).
IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances
The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Importance of Differential Diagnosis and Detailed Medical History
In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving Contact Dermatitis may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of flare-ups, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable guide for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond the direct physical manifestations, uncontrolled cases of contact dermatitis profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, reinforces the immune inflammatory response. Therefore, implementing a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being.
Frequently Asked Questions in Clinical Practice
Immunological Reactions to Insect Bites and Prevention of Crises: Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.
Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management: The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis: Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.
Immunology of Cutaneous Autoimmune Diseases and Integrated Care: Unlike purely IgE-mediated dermatoses, psoriasis and related autoimmune conditions involve the activation of plasmacytoid dendritic cells, interferon-gamma production, and sustained stimulation of the interleukin-23/interleukin-17 (IL-23/IL-17) and TNF-alpha axis. This signaling accelerates the epidermal keratinocyte renewal cycle several times over, resulting in well-defined erythematous-desquamative plaques and, in some patients, associated joint inflammation. Infections, mechanical or chemical trauma to the skin (Koebner phenomenon), dry winter weather, and emotional stress act as important amplifiers of the inflammatory response.
Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management: When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.
Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling: Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. For peaceful skin, free from constant itching and sleepless nights due to flare-ups.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Contact Dermatitis It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




